Ayala Pharmaceuticals EBIT margin
Qual é o EBIT margin de Ayala Pharmaceuticals?
O EBIT margin de Ayala Pharmaceuticals Inc. é -5,723.60%
Qual é a definição de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin de empresas na Setor Health Care em NASDAQ em comparação com Ayala Pharmaceuticals
O que Ayala Pharmaceuticals faz?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Empresas com ebit margin semelhantes a Ayala Pharmaceuticals
- Entheon Biomedical tem EBIT margin de -6,027.18%
- Green Hygienics tem EBIT margin de -6,022.25%
- VYNE Therapeutics tem EBIT margin de -5,849.18%
- Desert Metals tem EBIT margin de -5,802.10%
- Rafael Inc tem EBIT margin de -5,782.78%
- Clene Nanomedicine tem EBIT margin de -5,778.73%
- Ayala Pharmaceuticals tem EBIT margin de -5,723.60%
- Touchpoint tem EBIT margin de -5,664.29%
- Lyra Therapeutics tem EBIT margin de -5,567.64%
- Proseed India tem EBIT margin de -5,566.02%
- Energous Corp tem EBIT margin de -5,285.48%
- Orgenesis Inc tem EBIT margin de -5,274.17%
- Zonetail tem EBIT margin de -5,268.44%